Phathom Pharmaceuticals, Inc.

Historical 13F Holders

Symbol
PHAT
CUSIP
71722W107
All holders as of
Q2 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q3 18 8.37 M $98.8 M
2025 Q2 128 57.4 M $551 M
2025 Q1 145 64.0 M $401 M
2024 Q4 151 66.7 M $541 M
2024 Q3 140 72.8 M $1.31 B
2024 Q2 121 59.0 M $608 M
2024 Q1 123 56.0 M $595 M
2023 Q4 125 54.6 M $508 M
2023 Q3 116 43.8 M $453 M
2023 Q2 109 42.8 M $613 M
2023 Q1 89 30.8 M $220 M
2022 Q4 91 28.7 M $322 M
2022 Q3 98 30.2 M $334 M
2022 Q2 97 27.3 M $237 M
2022 Q1 85 25.7 M $349 M
2021 Q4 86 28.6 M $562 M
2021 Q3 87 25.5 M $820 M
2021 Q2 80 24.9 M $844 M
2021 Q1 85 24.5 M $919 M
2020 Q4 82 24.6 M $816 M
2020 Q3 60 21.6 M $794 M
2020 Q2 62 21.8 M $719 M
2020 Q1 49 22.0 M $566 M
2019 Q4 42 22.0 M $682 M